Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.21.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current Assets    
Cash $ 426,268 $ 1,170,301
Prepaid expenses and other current assets 266,237 149,725
Receivable from related party 13,910  
Total current assets 706,415 1,320,026
Cash and marketable securities held in Trust Account 202,034,396 202,029,414
Interest receivable on cash and marketable securities held in the Trust Account 1,830 1,716
Other non-current assets 13,708 43,083
TOTAL ASSETS 202,756,349 203,394,239
Current liabilities    
Accounts payable 63,066 84,089
Payable to related parties 15,136 5,778
Accrued liabilities 2,195,304 1,805,980
Other current liabilities 1,070 363
Total current liabilities 2,274,576 1,896,210
Deferred underwriting fee payable 8,000,000 8,000,000
Warrant liability 1,427,330 2,338,677
Total liabilities 11,701,906 12,234,887
Commitments and contingencies (Note 5)
Common stock subject to possible redemption, 18,421,231 and 18,431,618 shares as of March 31, 2021 and December 31, 2020, respectively, at a redemption value of $10.10 per share 186,054,433 186,159,342
Stockholders’ equity    
Preferred stock, par value of $0.0001 per share; 1,000,000 shares authorized; none issued or outstanding
Common stock, par value of $0.0001 per share; 100,000,000 shares authorized; 7,472,248 and 7,461,861 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively 747 746
Additional paid-in capital 9,885,571 9,780,663
Accumulated deficit (4,886,308) (4,781,399)
Total stockholders’ equity 5,000,010 5,000,010
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ EQUITY $ 202,756,349 $ 203,394,239